EFFECT OF SLOW-RELEASE IL-12 AND IL-10 ON INFLAMMATION, LOCAL MACROPHAGE FUNCTION AND THE REGIONAL LYMPHOID RESPONSE DURING MYCOBACTERIAL (TH1) AND SCHISTOSOMAL (TH2) ANTIGEN-ELICITED PULMONARY GRANULOMA-FORMATION
Sw. Chensue et al., EFFECT OF SLOW-RELEASE IL-12 AND IL-10 ON INFLAMMATION, LOCAL MACROPHAGE FUNCTION AND THE REGIONAL LYMPHOID RESPONSE DURING MYCOBACTERIAL (TH1) AND SCHISTOSOMAL (TH2) ANTIGEN-ELICITED PULMONARY GRANULOMA-FORMATION, Inflammation research, 46(3), 1997, pp. 86-92
Objective and Design: This study examines the local and regional effec
ts of exogenously administered interleukins 10 (IL-10) and 12 (IL-12)
on pulmonary granulomas mediated by Th1/type 1-(IFN-gamma) and Th2/typ
e 2-(IL-4, IL-5) cytokines. Materials and Treatments: Granulomas (GR)
were induced in presensitized CBA mice by embolization of beads coated
with Mycobacteria tuberculosis or Schistosoma mansoni egg antigens. B
efore challenge, osmotic pumps distributing IL-10 or IL-12 (50 mu g/kg
/day) were implanted intraperitoneally, then GR and draining lymph nod
es were examined 4 days. Methods: GR sizes and composition were determ
ined by morphometry and differential analysis. Isolated GR macrophages
and draining lymph nodes were assessed for cytokine production by ELI
SA. Results: IL-10 did not effect GR sizes but reduced neutrophils in
type 1 GR. IL-12 minimally reduced type 1 GR but decreased the type 2
lesion by up to 70%, primarily curtailing eosinophils. Type 2 GR macro
phages were unaffected but type 1 were impaired by IL-10. Conversely,
type 1 GR macrophages were more resistant to IL-12 while type 2 showed
enhanced IL-10, IL-12 and TNF, but reduced MCP-1 production. In lymph
nodes, IL-10 caused paradoxical effects, enhancing IFN-gamma in the t
ype 1 and decreasing Th2 cytokines in the type 2 response. Exogenous I
L-12 profoundly augmented IFN-gamma and abrogated type 2 cytokines whi
le inhibiting intrinsic IL-12 production in lymph nodes. Conclusion: T
hese findings provide novel information regarding cytokine regulation
and the effects of systemic cytokine therapy.